Pseudophakic corneal edema: A review of mechanisms and treatments

Cornea

Volumn 25, Issue 9, 2006, Pages 993-1004

  Narayanan, Raja ^a   Gaster, Ronald N ^a,b   Kenney, M Cristina ^a,c  

^a L V PRASAD EYE INSTITUTE   (India)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Mechanisms; Pseudophakic corneal edema; Review; Treatments

Indexed keywords

AQUAPORIN; AQUAPORIN 3; AQUAPORIN 7; AQUAPORIN 8; AQUAPORIN 9; FIBRILLIN 1; GROWTH FACTOR; HYPERTONIC SOLUTION; INTEGRIN; SODIUM CHLORIDE; SOMATOMEDIN; STEROID;

CELL MOTION; CORNEA EDEMA; CORNEA ENDOTHELIUM; CORNEA OPACITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; INSTRUMENTATION; KERATECTOMY; LENS IMPLANT; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PENETRATING KERATOPLASTY; PHOTOREFRACTIVE KERATECTOMY; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TREATMENT INDICATION;

CATARACT EXTRACTION; CORNEAL EDEMA; ENDOTHELIUM, CORNEAL; HUMANS; KERATOPLASTY, PENETRATING; LENS IMPLANTATION, INTRAOCULAR; POSTOPERATIVE COMPLICATIONS; PSEUDOPHAKIA;

EID: 33845368064     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000214225.98366.83     Document Type: Review

References (162)

1. Kenney MC, Chwa M. Abnormal extracellular matrix in corneas with pseudophakic bullous keratopathy. Cornea. 1990;9:115-121.
2. Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci. 1996;37:997-1007.
3. Waring GO III, Bourne WM, Edelhauser HF, et al. The corneal endothelium. Normal and pathologic structure and function. Ophthalmology. 1982;89:531-590.
4. Waring GO III, Rodrigues MM, Laibson PR. Corneal dystrophies. I. Dystrophies of the epithelium, Bowman's layer and stroma. Surv Ophthalmol. 1978;23:71-122.
5. Smith JW. The transparency of the corneal stroma. Vision Res. 1970;10:109-110.
6. Maurice DM. The structure and transparency of the cornea. J Physiol. 1957;136:263-286.
7. Meek KM, Leonard DW, Connon CJ, et al. Transparency, swelling and scarring in the corneal stroma. Eye. 2003;17:927-936.
8. Jester JV, Moller-Pedersen T, Huang I, et al. The cellular basis of corneal transparency: evidence for 'corneal crystallins.' J Cell Sci. 1999;112:613-622.
9. Stiemke MM, McCartney MD, Cantu-Crouch D, et al. Maturation of the corneal endothelial tight junction. Invest Ophthalmol Vis Sci. 1991;32:2757-2765.
10. Stern ME, Edelhauser HF, Pederson HJ, et al. Effects of ionophores X537a and A23187 and calcium-free medium on corneal endothelial morphology. Invest Ophthalmol Vis Sci. 1981;20:497-508.
11. Edelhauser HF, Van Horn DL, Miller P, et al. Effect of thiol-oxidation of glutathione with diamide on corneal endothelial function, junctional complexes, and microfilaments. J Cell Biol. 1976;68:567-578.
12. Riley MV, Winkler BS, Starnes CA, et al. Regulation of corneal endothelial barrier function by adenosine, cyclic AMP, and protein kinases. Invest Ophthalmol Vis Sci. 1998;39:2076-2084.
13. Green K, Hull DS, Vaughn ED, et al. Rabbit endothelial response to opthalmic preservatives. Arch Ophthalmol. 1977;95:2218-2221.
14. Nakamura M, Nakano T, Hikida M. Effects of oxidized glutathione and reduced glutathione on the barrier function of the corneal endothelium. Cornea. 1994;13:493-495.
15. Maurice DM. The permeability to sodium ions of the living rabbit's cornea. J Physiol. 1951;112:367-391.
16. King LS, Yasui M, Agre P. Aquaporins in health and disease. Mol Med Today. 2000;6:60-65.
17. Agre P, Kozono D. Aquaporin water channels: molecular mechanisms for human diseases. FEBS Lett. 2003;555:72-78.
18. Verkman AS. Role of aquaporin water channels in eye function. Exp Eye Res. 2003;76:137-143.
19. Kang F, Kunyan K, Fischbarg J. Cultured bovine corneal epithelial cells express functional water channel. Chung-Hua Yen K'o Tsa Chih. 2000;36:381-383.
20. Verkman AS. Physiological importance of aquaporin water channels. Ann Med. 2002;34:192-200.
21. Ikeda M, Beitz E, Kozono D, et al. Characterization of aquaporin-6 as a nitrate channel in mammalian cells. Requirement of pore-lining residue threonine 63. J Biol Chem. 2002;277:39873-39879.
22. Kenney MC, Atilano SR, Zorapapel N, et al. Altered expression of aquaporins in bullous keratopathy and Fuchs' dystrophy corneas. J Histochem Cytochem. 2004;52:1341-1350.
23. Liu E, Slomovic AR. Indications for penetrating keratoplasty in Canada, 1986-1995. Cornea. 1997;16:414-419.
24. Speaker MG, Lugo M, Laibson PR, et al. Penetrating keratoplasty for pseudophakic bullous keratopathy. Management of the intraocular lens. Ophthalmology. 1988;95:1260-1268.
25. Cohen EJ, Brady SE, Leavitt K, et al. Pseudophakic bullous keratopathy. Am J Ophthalmol. 1988;106:264-269.
26. Insler MS, Robbins RG. Fellow eyes in aphakic and pseudophakic bullous keratopathy. J Cataract Refract Surg. 1990;16:92-95.
27. Koenig SB, Schultz RO. Penetrating keratoplasty for pseudophakic bullous keratopathy after extracapsular cataract extraction. Am J Ophthalmol. 1988;105:348-353.
28. Cosar CB, Sridhar MS, Cohen EJ, et al. Indications for penetrating keratoplasty and associated procedures, 1996-2000. Cornea. 2002;21:148-151.
29. Dobbins KR, Price FW Jr, Whitson WE. Trends in the indications for penetrating keratoplasty in the Midwestern United States. Cornea. 2000;19:813-816.
30. Berkowitz P, Orton RB, Boyaner D, et al. Pseudophakic bullous keratophaty. A clinical-pathologic analysis. Can J Ophthalmol. 1979;14:3-9.
31. van der Schaft TL, van Rij G, Renardel de Lavalette JG, et al. Results of penetrating keratoplasty for pseudophakic bullous keratopathy with the exchange of an intraocular lens. Br J Ophthalmol. 1989;73:704-708.
32. Luchs JI, Cohen EJ, Rapuano CJ, et al. Ulcerative keratitis in bullous keratopathy. Ophthalmology. 1997;104:816-822.
33. Joyce NC. Proliferative capacity of the corneal endothelium. Prog Retin Eye Res. 2003;22:359-389.
34. Lugo M, Cohen EJ, Eagle RC Jr, et al. The incidence of preoperative endothelial dystrophy in pseudophakic bullous keratopathy. Ophthalmic Surg. 1988;19:16-19.
35. Arentsen JJ, Laibson PR. Surgical management of pseudophakic corneal edema: complications and visual result following penetrating keratoplasty. Ophthalmic Surg. 1982;13:371-373.
36. Waltman SR. Penetrating keratoplasty for pseudophakic bullous keratopathy. Visual results. Arch Ophthalmol. 1981;99:415-416.
37. Arentsen JJ, Donoso R, Laibson PR, et al. Penetrating keratoplasty for the treatment of pseudophakic corneal edema associated with posterior chamber lens implantation. Ophthalmic Surg. 1987;18:514-517.
38. Taylor DM, Atlas BF, Romanchuk KG, et al. Pseudophakic bullous keratopathy. Ophthalmology. 1983;90:19-24.
39. Bourne RR, Minassian DC, Dart JK, et al. Effect of cataract surgery on the corneal endothelium: modern phacoemulsification compared with extracapsular cataract surgery. Ophthalmology. 2004;111:679-685.
40. Hayashi K, Hayashi H, Nakao F, et al. Risk factors for corneal endothelial injury during phacoemulsification. J Cataract Refract Surg. 1996;22:1079-1084.
41. Glasser DB, Schultz RO, Hyndiuk RA. The role of viscoelastics, cannulas, and irrigating solution additives in post-cataract surgery corneal edema: a brief review. Lens Eye Toxic Res. 1992;9:351-359.
42. Miller KM, Colvard DM. Randomized clinical comparison of Healon GV and Viscoat. J Cataract Refract Surg. 1999;25:1630-1636.
43. Rao GN, Aquavella JV, Goldberg SH, et al. Pseudophakic bullous keratopathy. Relationship to preoperative corneal endothelial status. Ophthalmology. 1984;91:1135-1140.
44. Roberts CW, Boruchoff SA, Kenyon KR. The fellow eye of patients with aphakic bullous keratopathy. Cornea. 1984;3:250-255.
45. Bates AK, Cheng H, Hiorns RW. Pseudophakic bullous keratopathy: relationship with endothelial cell density and use of a predictive cell loss model. A preliminary report. Curr Eye Res. 1986;5:363-366.
46. Kaufman E, Katz JI. Endothelial damage from intraocular lens insertion. Invest Ophthalmol. 1976;15:996-1000.
47. Sugar J, Burnett J, Forstol SL. Scanning electron microscopy of intraocular lens and endothelial cell interaction. Am J Ophthalmol. 1978;86:157-161.
48. Mateo NB, Ratner BD. Relating the surface properties of intraocular lens materials to endothelial cell adhesion damage. Invest Ophthalmol Vis Sci. 1989;30:853-860.
49. Kaufman HE, Katz JI. Effect of intraocular lenses on the corneal endothelium. Trans Ophthalmol Soc U K. 1977;77:265-267.
50. Courtright P, Lewallen S, Holland SP, et al. Corneal decompensation after cataract surgery. An outbreak investigation in Asia. Ophthalmology. 1995;102:1461-1465.
51. Breebaart AC, Nuyts RM, Pels E, et al. Toxic endothelial cell destruction of the cornea after routine extracapsular cataract surgery. Arch Ophthalmol. 1990;108:1121-1125.
52. Nuyts RM, Edelhauser HF, Pels E, et al. Toxic effects of detergents on the corneal endothelium. Arch Ophthalmol. 1990;108:1158-1162.
53. Duffy RE, Brown SE, Caldwell KL, et al. An epidemic of corneal destruction caused by plasma gas sterilization. The Toxic Cell Destruction Syndrome Investigative Team. Arch Ophthalmol. 2000;118:1167-1176.
54. Parikh CH, Edelhauser HF. Ocular surgical pharmacology: corneal endothelial safety and toxicity. Curr Opin Ophthalmol. 2003;14:178-185.
55. Lois N, Kowal VO, Cohen EJ, et al. Indications for penetrating keratoplasty and associated procedures, 1987-1995. Cornea. 1997;16:623-629.
56. Sharif KW, Casey TA. Changing indications for penetrating keratoplasty, 1971-1990. Eye. 1993;7:485-488.
57. Robin JE, Gindi JJ, Koh K, et al. An update of the indications for penetrating keratoplasty. 1979 through 1983. Arch Ophthalmol. 1986;104:87-89.
58. Sugar A, Meyer RF, Heidemann D, et al. Specular microscopic follow-up of corneal grafts for pseudophakic bullous keratopathy. Ophthalmology. 1985;92:325-330.
59. Smith PW, Wong SK, Stark WJ, et al. Complications of semiflexible, closed-loop anterior chamber intraocular lenses. Arch Ophthalmol. 1987;105:52-57.
60. Gaster RN, Troutman RC, Ong HV, et al. Combined penetrating keratoplasty and posterior chamber intraocular lens implantation in the absence of a lens capsule. Trans Am Ophthalmol Soc. 1990;88:326-339. discussion 39-42.
61. Kandarakis AS, Doulas KG, Amariotakis AG. Penetrating keratoplasty and transsclerally suture-fixated intraocular lenses. J Refract Surg. 1996;12:S304-S306.
62. Binkhorst CD. Corneal and retinal complications after cataract extraction. The mechanical aspect of endophthalmodonesis. Ophthalmology. 1980;87:609-617.
63. Drews RC. The Barraquer experience with intraocular lenses. 20 Years later. Ophthalmology. 1982;89:386-393.
64. Drews RC. Lens implantation: lessons learned from the first million. The Third Rayner Lecture, 1982. Trans Ophthalmol Soc U K. 1982;102:505-509.
65. Drews RC. Quality control, and changing indications for lens implantation. The Seventh Binkhorst Medal Lecture - 1982. Ophthalmology. 1983;90:301-310.
66. Moses L. Complications of rigid anterior chamber implants. Ophthalmology. 1984;91:819-825.
67. Ellingson FT. The uveitis-glaucoma-hyphema syndrome associated with the Mark VIII anterior chamber lens implant. J Am Intraocul Implant Soc. 1978;4:50-53.
68. Apple DJ, Hansen SO, Richards SC, et al. Anterior chamber lenses. Part II: a laboratory study. J Cataract Refract Surg. 1987;13:175-189.
69. Poleski SA, Willis WE. Angle-supported intraocular lenses: a goniophotographic study. Ophthalmology. 1984;91:838-840.
70. Drews RC. Intermittent touch syndrome. Arch Ophthalmol. 1982;100:1440-1441.
71. Canner JK, Javitt JC, McBean AM. National outcomes of cataract extraction. III. Corneal edema and transplant following inpatient surgery. Arch Ophthalmol. 1992;110:1137-1142.
72. Kremer I, Stiebel H, Yassur Y, et al. Sulfur hexafluoride injection for Descemet's membrane detachment in cataract surgery. J Cataract Refract Surg. 1997;23:1449-1453.
73. Gault JA, Raber IM. Repair of Descemet's membrane detachment with intracameral injection of 20% sulfur hexafluoride gas. Cornea. 1996;15:483-489.
74. Shah M, Bathia J, Kothari K. Repair of late Descemet's membrane detachment with perfluoropropane gas. J Cataract Refract Surg. 2003;29:1242-1244.
75. Macsai MS, Gainer KM, Chisholm L. Repair of Descemet's membrane detachment with perfluoropropane (C3F8). Cornea. 1998;17:129-134.
76. Jurgens I. Repair of Descemet's membrane detachment with sulfur hexafluoride. Cornea. 1996;15:439-440.
77. Ellis DR, Cohen KL. Sulfur hexafluoride gas in the repair of Descemet's membrane detachment. Cornea. 1995;14:436-437.
78. Zusman NB, Waring GO III, Najarian LV, et al. Sulfur hexafluoride gas in the repair of intractable Descemet's membrane detachment. Am J Ophthalmol. 1987;104:660-662.
79. Brown SI, McLean JM. Peripheral corneal edema after cataract extraction. A new clinical entity. Trans Am Acad Ophthalmol Otolaryngol. 1969;73:465-470.
80. Gothard TW, Hardten DR, Lane SS, et al. Clinical findings in Brown-McLean syndrome. Am J Ophthalmol. 1993;115:729-737.
81. Kangas TA, Edelhauscr HF, Twining SS, et al. Loss of stromal glycosaminoglycans during corneal edema. Invest Ophthalmol Vis Sci. 1990;31:1994-2002.
82. Saghizadeh M, Khin HL, Bourdon MA, et al. Novel splice variants of human tenascin-C mRNA identified in normal and bullous keratopathy corneas. Cornea. 1998;17:326-332.
83. Ljubimov AV, Saghizadeh M, Spirin KS, et al. Expression of tenascin-C splice variants in normal and bullous keratopathy human corneas. Invest Ophthalmol Vis Sci. 1998;39:1135-1142.
84. Ljubimov AV, Saghizadeh M, Spirin KS, et al. Increased expression of fibrillin-1 in human corneas with bullous keratopathy. Cornea. 1998;17:309-314.
85. Ashcroft GS, Kielty CM, Horan MA, et al. Age-related changes in the temporal and spatial distributions of fibrillin and elastin mRNAs and proteins in acute cutaneous wounds of healthy humans. J Pathol. 1997;183:80-89.
86. Maguen E, Alba SA, Rurgeson RE, et al. Alterations of corneal extracellular matrix after multiple refractive procedures: a clinical and immunohistochemical study. Cornea. 1997;16:675-682.
87. Lauweryns B, van den Oord JJ, Missotten L. Localization of the cytoadhesin integrins in the human cornea. An immunohistochemical study using monoclonal antibodies. Graefes Arch Clin Exp Ophthalmol. 1992;230:264-268.
88. Kenney MC, Chwa M, Alba A, et al. Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. Curr Eye Res. 1998;17:238-246.
89. Kvanta A, Sarman S, Fagerholm P, et al. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation associated corneal neovascularization. Exp Eye Res. 2000;70:419-428.
90. Ye HQ, Azar DT. Expression of gelatinases A and B, and TIMPs 1 and 2 during cornealwound healing. Invest Ophthalmol Vis Sci. 1998;39:913-921.
91. Mohan RR, Hutcheon AE, Choi R, et al. Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Exp Eye Res. 2003;76:71-87.
92. Nakamura K, Kurosaka D, Yoshino M, et al. Injured corneal epithelial cells promote myodifferentiation of corneal fibroblasts. Invest Ophthalmol Vis Sci. 2002;43:2603-2608.
93. Jester JV, Petroll WM, Cavanagh HD. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog Retin Eye Res. 1999;18:311-356.
94. Kenney MC, Chwa M, Lin B, et al. Identification of cell types in human diseased corneas. Cornea. 2001;20:309-316.
95. Jones FS, Jones PL. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn. 2000;218:235-259.
96. Spirin KS, Ljubimov AV, Castellon R, et al. Analysis of gene expression in human bullous keratopathy corneas containing limiting amounts of RNA. Invest Ophthalmol Vis Sci. 1999;40:3108-3115.
97. Borradori L, Sonnenberg A. Hemidesmosomes: roles in adhesion, signaling and human diseases. Curr Opin Cell Biol. 1996;8:647-656.
98. van der Neut R, Krimpenfort P, Calafat J, et al. Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice. Nat Genet. 1996;13:366-369.
99. Ljubimov AV, Saghizadeh M, Pytela R, et al. Increased expression of tenascin-C-binding epithelial integrins in human bullous keratopathy corneas. J Histochem Cytochem. 2001;49:1341-1350.
100. Stepp MA, Zhu L, Cranfill R. Changes in beta 4 integrin expression and localization in vivo in response to corneal epithelial injury. Invest Ophthalmol Vis Sci. 1996;37:1593-1601.
101. Zhou L, Yue BY, Twining SS, et al. Expression of wound healing and stress-related proteins in keratoconus corneas. Curr Eye Res. 1996;15:1124-1131.
102. Rosenbaum JT, Planck ST, Huang XN, et al. Detection of mRNA for the cytokines, interleukin-1 alpha and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy. Invest Ophthalmol Vis Sci. 1995;36:2151-2155.
103. Saghizadeh M, Chwa M, Aoki A, et al. Altered expression of growth factors and cytokines in keratoconus, bullous keratopathy and diabetic human corneas. Exp Eye Res. 2001;73:179-189.
104. Kenney MC, Zorapapel N, Atilano S, et al. Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta (TGF-beta) modulate tenascin-C and fibrillin-1 in bullous keratopathy stromal cells in vitro. Exp Eye Res. 2003;77:537-546.
105. Agre P, King LS, Yasui M, et al. Aquaporin water channels - from atomic structure to clinical medicine. J Physiol. 2002;542:3-16.
106. Papadopoulos MC, Krishna S, Verkman AS. Aquaporin water channels and brain edema. Mt Sinai J Med. 2002;69:242-248.
107. Macnamara E, Sams GW, Smith K, et al. Aquaporin-1 expression is decreased in human and mouse corneal endothelial dysfunction. Mol Vis. 2004;10:51-56.
108. +-ATPase in human corneas following cataract surgery: comparison with bullous keratopathy and Fuchs' dystrophy corneas. Cornea. 2002;21:74-80.
109. Marisi A, Aquavella JV. Hypertonic saline solution in corneal edema. Ann Ophthalmol. 1975;7:229-233.
110. Luxenberg MN, Green K. Reduction of corneal edema with topical hypertonic agents. Am J Ophthalmol. 1971;71:847-853.
111. Insler MS, Benefield DW, Ross EV. Topical hyperosmolar solutions in the reduction of corneal edema. CLAO J. 1987;13:149-151.
112. Green K, Downs S. Reduction of corneal thickness with hypertonic solutions. Am J Ophthalmol. 1973;75:507-510.
113. Takahashi GH, Leibowitz HM. Hydrophilic contact lenses in corneal disease. 3. Topical hypertonic saline therapy in bullous keratopathy. Arch Ophthalmol. 1971;86:133-137.
114. Leibowitz HM, Rosenthal P. Hydrophilic contact lenses in corneal disease. II. Bullous keratopathy. Arch Ophthalmol. 1971;85:283-285.
115. Arora R, Jain S, Monga S, et al. Efficacy of continuous wear Pure Vision contact lenses for therapeutic use. Cont Lens Anterior Eye. 2004;27:39-43.
116. Lim L, Tan DT, Chan WK. Therapeutic use of Bausch & Lomb PureVision contact lenses. CLAO J. 2001;27:179-185.
117. Figueiredo RS, Araujo SV, Cohen EJ, et al. Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C. Ophthalmic Surg Lasers. 1996;27:903-909.
118. Beebe WE, Starita RJ, Fellman RL, et al. The use of Molteno implant and anterior chamber tube shunt to encircling band for the treatment of glaucoma in keratoplasty patients. Ophthalmology. 1990;97:1414-1422.
119. McDonnell PJ, Robin JB, Schanzlin DJ, et al. Molteno implant for control of glaucoma in eyes after penetrating keratoplasty. Ophthalmology. 1988;95:364-369.
120. Fechtner RD. Management of coexisting pseudophakic bullous keratopathy and open-angle glaucoma. J Glaucoma. 1998;7:58-61.
121. Busin M, Arffa RC, Sebastiani A. Endokeratoplasty as an alternative to penetrating keratoplasty for the surgical treatment of diseased endothelium: initial results. Ophthalmology. 2000;107:2077-2082.
122. Melles GR, Lander F, Beekhuis WH, et al. Posterior lamellar keratoplasty for a case of pseudophakic bullous keratopathy. Am J Ophthalmol. 1999;127:340-341.
123. Van Dooren B, Mulder PG, Nieuwendaal CP, et al. Endothelial cell density after posterior lamellar keratoplasty (Melles technique): 3 years follow-up. Am J Ophthalmol. 2004;138:211-217.
124. Gasset AR, Kaufman HE. Bandage lenses in the treatment of bullous keratopathy. Am J Ophthalmol. 1971;72:376-380.
125. Ruben M. Soft contact lens treatment of bullous keratopathy. Trans Ophthalmol Soc U K. 1975;95:75-78.
126. Cormier G, Brunette I, Boisjoly HM, et al. Anterior stromal punctures for bullous keratopathy. Arch Ophthalmol. 1996;114:654-658.
127. Sridhar MS, Vemuganti GK, Bansal AK, et al. Anterior stromal puncture in bullous keratopathy: a clinicopathologic study. Cornea. 2001;20:573-579.
128. Rubinfeld RS, Laibson PR, Cohen EJ, et al. Anterior stromal puncture for recurrent erosion: further experience and new instrumentation. Ophthalmic Surg. 1990;21:318-326.
129. McLean EN, MacRae SM, Rich LF. Recurrent erosion. Treatment by anterior stromal puncture. Ophthalmology. 1986;93:784-788.
130. Katsev DA, Kincaid MC, Fouraker BD, et al. Recurrent corneal erosion: pathology of corneal puncture. Cornea. 1991;10:418-423.
131. Hsu JK, Ruhinfeld RS, Barry P, et al. Anterior stromal puncture. Immunohistochemical studies in human corneas. Arch Ophthalmol. 1993;111:1057-1063.
132. Maini R, Sullivan L, Snibson GR, et al. A comparison of different depth ablations in the treatment of painful bullous keratopathy with phototherapeutic keratectomy. Br J Ophthalmol. 2001;85:912-915.
133. Lin PY, Wu CC, Lee SM. Combined phototherapeutic keratectomy and therapeutic contact lens for recurrent erosions in bullous keratopathy. Br J Ophthalmol. 2001;85:908-911.
134. Thomann U, Niesen U, Schipper I. Successful phototherapeutic keratectomy for recurrent erosions in bullous keratopathy. J Refract Surg. 1996;12:5290-5292.
135. Wood TO. Recurrent erosion. Trans Am Ophthalmol Soc. 1984;82:850-898.
136. DeVoe A. Electrocautery of Bowman's membrane. Arch Ophthalmol. 1966;76:768-771.
137. Koenig SB. Annular keratotomy for the treatment of painful bullous keratopathy. Am J Ophthalmol. 1996;121:93-94.
138. Mejia LF, Acosta C. Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea. 2002;21:342-345.
139. Pires RT, Tseng SC, Prabhasawat P, et al. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol. 1999;117:1291-1297.
140. Espana EM, Grueterich M, Sandoval H, et al. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg. 2003;29:279-284.
141. Zito E, Borderie V, Touzeau O, et al. Amniotic membrane transplantation in severe corneal epithelial diseases. Preliminary results. J Fr Ophthalmol. 2002;25:879-888.
142. Alino AM, Perry HD, Kanellopoulos AJ, et al. Conjunctival flaps. Ophthalmology. 1998;105:1120-1123.
143. Smith R. Surgical relief of bullous keratopathy. (Gunderson's operation). Trans Ophthalmol Soc U K. 1965;85:307-316.
144. Tsai TC, Su CY, Lin CP. Anterior stromal puncture for bullous keratopathy. Ophthalmic Surg Lasers Imaging. 2003;34:371-374.
145. Gomes JA, Haraguchi DK, Zambrano DU, et al. Anterior stromal puncture in the treatment of bullous keratopathy: six-month follow-up. Cornea. 2001;20:570-572.
146. Wong TY, Chan C, Lim L, et al. Changing indications for penetrating keratoplasty: a newly developed country's experience. Aust N Z J Ophthalmol. 1997;25:145-150.
147. Cursiefen C, Kuchle M, Naumann GO. Changing indications for penetrating keratoplasty: histopathology of 1,250 corneal buttons. Cornea. 1998;17:468-470.
148. Reidy JJ, Apple DJ, Googe JM, et al. An analysis of semiflexible, closed-loop anterior chamber intraocular lenses. J Am Intraocul Implant Soc. 1985;11:344-352.
149. Maynor RC Jr. Five cases of severe anterior chamber lens implant complications. J Am Intraocul Implant Soc. 1984;10:223-224.
150. McDonnell PJ, Green WR, Maumenee AE. Pathology of intraocular lenses in 33 eyes examined postmortem. Ophthalmology. 1983;90:386-403.
151. Kommehl EW, Steinert RF, Odrich MG, et al. Penetrating keratoplasty for pseudophakic bullous keratopathy associated with closed-loop anterior chamber intraocular lenses. Ophthalmology. 1990;97:407-412.
152. Terry MA, Ousley PJ. Small-incision deep lamellar endothelial keratoplasty (DLEK): six-month results in the first prospective clinical study. Cornea. 2005;24:59-65.
153. Ousley PJ, Terry MA. Stability of vision, topography, and endothelial cell density from 1 year to 2 years after deep lamellar endothelial keratoplasty surgery. Ophthalmology. 2005;112:50-57.
154. Fukuda K, Chikama T, Nakamura M, et al. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea. 1999;18:73-79.
155. Tseng SC, Prabhasawat P, Barton K, et al. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in 7 patients with limbal stem cell deficiency. Arch Ophthalmol. 1998;116:431-441.
156. Kurpakus MA, Stock EL, Jones JC. The role of the basement membrane in differential expression of keratin proteins in epithelial cells. Dev Biol. 1992;150:243-255.
157. Yeo TT, Chua-Couzens J, Butcher LL, et al. Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. J Neurosci. 1997;17:7594-7605.
158. Wang MX, Gray TB, Park WC, et al. Reduction in corneal haze and apoptosis by amniotic membrane matrix in excimer laser photoablation in rabbits. J Cataract Refract Surg. 2001;27:310-319.
159. Park WC, Tseng SC. Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK. Invest Ophthalmol Vis Sci. 2000;41:2906-2914.
160. Shimmura S, Shimazaki J, Ohashi Y, et al. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001;20:408-413.
161. Hao Y, Ma DH, Hwang DG, et al. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000;19:348-352.
162. Koizumi NJ, Inatomi TJ, Sotozono CJ, et al. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000;20:173-177.